2. Contoso
Pharmaceuticals
AboutUs
o We are a team of 5 frontline physicians,
inventors, and entrepreneurs in the fight
againstCOVID19
o A combined 70 years of experience taking
care of patients from birth to the end of life
o Over 100 publications
o Serve as leaders on numerous national
committees page 2
Brent Barta DO
Brigid Flynn MD
Tim Krause DO
Jay Nachtigal MD
Jared Staab DO,MA
6. Contoso
Pharmaceuticals
page 6
“While we can’t predict exactly when or where the next epidemic or
pandemic will begin, we know one is
coming…..Outbreaks take hold in the world’s most vulnerable areas – countries
with few resources to stem the tide of infection before it reaches our shores. When
pathogens can travel from a remote
village to major cities on all
continents in 36 hours, the threat to our national security is
greater than ever.…..Increased risk of infectious pathogens “spilling over” from animals to
humans…..Spread of infectious diseases through global travel and trade"
Contagion
Solutions
7. Contoso
Pharmaceuticals
TheProblem
Dangerous
Pathogens
Recurrent
threats and
newly emerging
disease place
billions at risk
Financial
Hospitals close,
healthcare
workers are
furloughed, and
the global
economy
collapses
Trust
When and
where is it safe
to get
healthcare?
What can I
believe? Should
I have my heart
attack at home?
Cost
PPE is
expensive and
precious.
Throughput is
limited by air
turnover
decreasing
margins and
slowing down
the delivery of
healthcare
Margins
Converting
every medical
space into
negative
pressure
isolation
environments is
costly and
impractical page 7
Contagion
Solutions
8. Contoso
Pharmaceuticals
Portable
Ships flat and
assembles in seconds
inside an ambulance,
MRI scanner,
operating room, ICU,
and beyond
Affordable
Saves cost by
decreasing PPE
utilization and
increasing
throughput by cutting
down on terminal
clean and
aerosolization delays
Negative
Pressure
Brings the negative
pressure environment
to bedside
THESolution
Stop pathogens from entering
and spreading in your facility
Keep healthcare workers safe
Save time, money, but
mostly…SAVE….LIVES.
page 8
Contagion
Solutions
9. Contoso
Pharmaceuticals
Unique
Designed to solve a
problem that had no
reasonable solution.
First to Market
No other PPE device
delivers all these
features in a small
affordable package
Tested
Rigorous testing.
Authentic
Designed by those
who are in harms
way.
TheTent
Whether it is Ebola in Africa,
COVID in India, or H1N1 in China,
TheTent delivers safety, piece of
mind, and efficiency to current
pandemics and those that are
yet to come.
page 9
Contagion
Solutions
12. Contoso
Pharmaceuticals
BusinessModel
Reduce cost, increase throughput, keep our
heroes working, keep their families at ease
Hospitals
Rapidly contain
outbreaks, bring back
procedural efficiency
Ambulance
Rapidly deployable in
the field when
seconds count and all
is unknown
Governments
Disaster response,
and rapid
containment
page 12
Contagion
Solutions
18. Contoso
Pharmaceuticals
Knockingoutthecompetition
CAMIC
-Large volume
-Not disposable
-Needs cleaning
-Time to set up
and deploy?
-Shipping costs
and inventory
space?
-Cost?
page 18
NRSAVR-100
-LargeVolume
Chamber limits
ability to create
negative pressure
environment
-Not sealed off
from external
environment
The Dome
-LargeVolume
Chamber limits
negative pressure
environment
-One size fits all gloves
-Sealing with tape is
not effective
-Not sealed off from
external environment
Stat Enclosure
-EUA pulled
-No negative pressure
-Not sealed from external environment
19. Contoso
Pharmaceuticals
• .
page 19
Contagion
Solutions
Market Opportunity
Millions of EMS calls per year
48 Million surgeries in the US per year
(3-6% projected growth rate)
Over 100 million surgeries performed
per year internationally
Surgical volume above doubles when
including non-OR procedures
21. Contoso
Pharmaceuticals
The Ask
page 21
Contagion
Solutions
Seeking capital to support
-A CEO to help get theTent to market
-Boots on the ground for initial education and sales
-Cash to cover first 2 production runs
-Marketing campaign
-FDA certification
-International expansion
-R&D